These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

801 related items for PubMed ID: 22385293

  • 1. Meta-analysis of the relationship between ACE I/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy.
    Yu ZY, Chen LS, Zhang LC, Zhou TB.
    Nephrology (Carlton); 2012 Jul; 17(5):480-7. PubMed ID: 22385293
    [Abstract] [Full Text] [Related]

  • 2. The DD genotype of the ACE gene polymorphism is associated with progression of diabetic nephropathy to end stage renal failure in IDDM.
    Vleming LJ, van der Pijl JW, Lemkes HH, Westendorp RG, Maassen JA, Daha MR, van Es LA, van Kooten C.
    Clin Nephrol; 1999 Mar; 51(3):133-40. PubMed ID: 10099885
    [Abstract] [Full Text] [Related]

  • 3. Relationship of angiotensin-converting enzyme gene polymorphism with nephropathy associated with Type 2 diabetes mellitus in Asian Indians.
    Movva S, Alluri RV, Komandur S, Vattam K, Eppa K, Mukkavali KK, Mubigonda S, Saharia S, Shastry JC, Hasan Q.
    J Diabetes Complications; 2007 Mar; 21(4):237-41. PubMed ID: 17616353
    [Abstract] [Full Text] [Related]

  • 4. A meta-analysis of the association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease risk in IgA nephropathy patients.
    Zhou TB, Yin SS, Liang R.
    J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):235-41. PubMed ID: 23060471
    [Abstract] [Full Text] [Related]

  • 5. Identification of specific angiotensin-converting enzyme variants and haplotypes that confer risk and protection against type 2 diabetic nephropathy.
    Ezzidi I, Mtiraoui N, Kacem M, Chaieb M, Mahjoub T, Almawi WY.
    Diabetes Metab Res Rev; 2009 Nov; 25(8):717-24. PubMed ID: 19787680
    [Abstract] [Full Text] [Related]

  • 6. Association between genetic polymorphism of the angiotensin-converting enzyme and diabetic nephropathy: a meta-analysis comprising 26,580 subjects.
    Wang F, Fang Q, Yu N, Zhao D, Zhang Y, Wang J, Wang Q, Zhou X, Cao X, Fan X.
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):161-74. PubMed ID: 21810896
    [Abstract] [Full Text] [Related]

  • 7. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease in lebanese patients with diabetic nephropathy.
    Fawwaz S, Balbaa M, Fakhoury H, Borjac J, Fakhoury R.
    Saudi J Kidney Dis Transpl; 2017 Mar; 28(2):325-329. PubMed ID: 28352015
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
    Sakka Y, Babazono T, Sato A, Ujihara N, Iwamoto Y.
    Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
    [Abstract] [Full Text] [Related]

  • 11. Association between angiotensin-converting enzyme insertion/deletion gene polymorphism and end-stage renal disease susceptibility.
    Zhou TB, Yin SS, Qin YH.
    J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):22-31. PubMed ID: 23077080
    [Abstract] [Full Text] [Related]

  • 12. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
    Pereira TV, Nunes AC, Rudnicki M, Magistroni R, Albertazzi A, Pereira AC, Krieger JE.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
    [Abstract] [Full Text] [Related]

  • 13. The presence of allele D of angiotensin-converting enzyme polymorphism is associated with diabetic nephropathy in patients with less than 10 years duration of Type 2 diabetes.
    Canani LH, Costa LA, Crispim D, Gonçalves Dos Santos K, Roisenberg I, Lisbôa HR, Sarturi Tres G, Maia AL, Gross JL.
    Diabet Med; 2005 Sep; 22(9):1167-72. PubMed ID: 16108844
    [Abstract] [Full Text] [Related]

  • 14. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy].
    Liao L, Lei MX, Chen HL.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Angiotensin I converting enzyme gene polymorphism and diabetic nephropathy in type II diabetes.
    Schmidt S, Ritz E.
    Nephrol Dial Transplant; 1997 Dec; 12 Suppl 2():37-41. PubMed ID: 9269698
    [Abstract] [Full Text] [Related]

  • 18. Polymorphism of the ACE Gene in dialysis patients: overexpression of DD genotype in type 2 diabetic end-stage renal failure patients.
    Park HC, Choi SR, Kim BS, Lee TH, Kang BS, Choi KH, Lee HY, Han DS, Ha SK.
    Yonsei Med J; 2005 Dec 31; 46(6):779-87. PubMed ID: 16385653
    [Abstract] [Full Text] [Related]

  • 19. Association of angiotensin-converting enzyme insertion/deletion polymorphism with type 1 diabetic nephropathy: a meta-analysis.
    Xu HY, Liu MM, Wang X, He XY.
    Ren Fail; 2016 Oct 31; 38(9):1320-1327. PubMed ID: 27498976
    [Abstract] [Full Text] [Related]

  • 20. Renin-angiotensin system polymorphisms: a risk factor for progression to end-stage renal disease in vesicoureteral reflux patients.
    Akman B, Tarhan C, Arat Z, Sezer S, Ozdemir FN.
    Ren Fail; 2009 Oct 31; 31(3):196-200. PubMed ID: 19288324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.